QuantPi builds HIPAA-compliant AI systems for hospitals, pharmaceutical companies, and biotech firms. From clinical decision support to drug discovery — we deliver AI that clinicians trust and regulators approve.
Healthcare AI has enormous potential — but the stakes are higher than any other industry. A false negative in cancer screening can cost a life. A biased clinical model can create health disparities. QuantPi builds healthcare AI with the rigor and care these applications demand.
Our team includes engineers with deep domain expertise in clinical informatics, medical imaging, and pharmaceutical research. Every system we build is designed for HIPAA compliance, FDA-aligned validation, and clinical workflow integration from day one.
Schedule a DemoAI assistants that synthesize patient history, lab results, and clinical guidelines to support diagnostic and treatment decisions. Reduces diagnostic time by 40% while maintaining 94% accuracy.
Deep learning models for radiology, pathology, and dermatology. Automated detection of tumors, fractures, retinal diseases, and skin conditions with radiologist-level accuracy.
Quantum-enhanced ML models for molecular property prediction, protein folding, and drug-target interaction modeling. Accelerate early-stage discovery by 3× while reducing wet lab costs.
NLP pipelines that extract structured data from unstructured clinical notes, discharge summaries, and pathology reports. Automate coding, billing, and quality reporting.
Predictive models that identify high-risk patients for readmission, sepsis, deterioration, and chronic disease progression. Enable proactive intervention and resource allocation.
AI-powered patient matching, site selection, and protocol optimization that reduces recruitment time by 50% and improves trial diversity and retention.
A regional hospital network struggled with radiology backlogs. We deployed a deep learning model that pre-screens chest X-rays, flagging critical findings for immediate review — reducing report turnaround from 48 hours to 4 hours for urgent cases.
We build AI systems designed for FDA 510(k) and De Novo pathways, including clinical validation protocols. We partner with regulatory consultants for submission support.
End-to-end encryption, de-identification pipelines, BAA agreements, audit logging, and role-based access control. All processing occurs within your HIPAA-compliant environment.
Yes. We support FHIR R4, HL7 v2, and CDA interfaces. We have experience integrating with Epic, Cerner, Meditech, and Allscripts.
Multi-site retrospective validation, prospective clinical studies, and continuous monitoring with clinician feedback loops. We follow TRIPOD-AI and CONSORT-AI reporting guidelines.
Start with a technical conversation. No pitch decks, no pressure — just a discussion about what’s possible for your industry.